MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 0.26mg modified-release tablets (Boehringer Ingelheim Ltd).

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 0.26mg modified-release tablets (Boehringer Ingelheim Ltd).

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 0.26mg modified-release tablets (Boehringer Ingelheim Ltd).

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 0.26mg modified-release tablets (Boehringer Ingelheim Ltd).

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd).

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd).

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd).

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd).

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd).

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd).

Stability Notes

Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 0.35mg tablets (Boehringer Ingelheim Ltd) and Pramipexole 350microgram tablets (Accord Healthcare Ltd).

Stability Notes

Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 0.35mg tablets (Boehringer Ingelheim Ltd) and Pramipexole 350microgram tablets (Accord Healthcare Ltd).

Stability Notes

Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 0.35mg tablets (Boehringer Ingelheim Ltd) and Pramipexole 350microgram tablets (Accord Healthcare Ltd).

Stability Notes

Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 0.35mg tablets (Boehringer Ingelheim Ltd) and Pramipexole 350microgram tablets (Accord Healthcare Ltd).

Stability Notes

Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 0.35mg tablets (Boehringer Ingelheim Ltd) and Pramipexole 350microgram tablets (Accord Healthcare Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.